Daiwa Securities Group’s Clovis Oncology, Inc. CLVS Stock Holding History

Daiwa Securities Group’s Portfolio CLVS Stock Details CLVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-406	Closed	–	–	1433
2022 Q3	$0	Hold	406	–	–	﹤0.01%	1435
2022 Q2	$1K	Hold	406	–	–	﹤0.01%	1341
2022 Q1	$1K	Hold	406	–	–	﹤0.01%	1368
2021 Q4	$1K	Hold	406	–	–	﹤0.01%	1380
2021 Q3	$2K	Buy	406 +240	+145%	+$1.16K	﹤0.01%	1255
2021 Q2	$1K	Hold	166	–	–	﹤0.01%	1247
2021 Q1	$1K	Hold	166	–	–	﹤0.01%	1259
2020 Q4	$1K	Buy	+166	New	+$840	﹤0.01%	1240
2019 Q4	–	Sell	-336	Closed	-$1K	–	1263
2019 Q3	$1K	Hold	336	–	–	﹤0.01%	1170
2019 Q2	$5K	Hold	336	–	–	﹤0.01%	1112
2019 Q1	$8K	Buy	336 +65	+24%	+$1.63K	﹤0.01%	1050
2018 Q4	$5K	Hold	271	–	–	﹤0.01%	1064
2018 Q3	$8K	Hold	271	–	–	﹤0.01%	1061
2018 Q2	$12K	Hold	271	–	–	﹤0.01%	1046
2018 Q1	$14K	Buy	+271	New	+$15.8K	﹤0.01%	1008

Other funds holding CLVS

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

CAS

Coppell Advisory Solutions Coppell, Texas $170M AUM 13.42% 1-Year Est. Return

CASC

Coppell Advisory Solutions Corp Coppell, Texas $531M AUM

STB

S&T Bank Indiana, Pennsylvania $268M AUM 39.92% 1-Year Est. Return

MCM

MAI Capital Management Independence, Ohio $17.7B AUM 18.87% 1-Year Est. Return

Wedbush Securities Los Angeles, California $3.43B AUM 24.13% 1-Year Est. Return

FFWM

Future Financial Wealth Management Cincinnati, Ohio $155M AUM 13% 1-Year Est. Return

NFSG

Newbridge Financial Services Group Boca Raton, Florida $608M AUM 31.28% 1-Year Est. Return

Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return

Daiwa Securities Group's CLVS Position: Q4 2022 in Review

Daiwa Securities Group sold out of Clovis Oncology, Inc. (CLVS) in Q4 2022, closing a stake of 406 shares.

Daiwa Securities Group first reported a position in CLVS in Q1 2018 and held it in 15 quarters. The position peaked at $14K in Q1 2018. 15 funds tracked by Wall St. Rank hold CLVS as of Q4 2022.

Daiwa Securities Group reported no remaining Clovis Oncology, Inc. position as of Q4 2022 after selling out during the quarter.
Daiwa Securities Group sold 406 Clovis Oncology, Inc. shares in Q4 2022.
Daiwa Securities Group first reported a position in Clovis Oncology, Inc. in Q1 2018 and held it in 15 quarters.
Daiwa Securities Group's Clovis Oncology, Inc. position peaked at $14K in Q1 2018.
15 funds tracked by Wall St. Rank held Clovis Oncology, Inc. as of Q4 2022.

Based on Daiwa Securities Group's 13F filing for Q4 2022, filed 6 Feb 2023.